Abstract
This article describes the preparation of 99Mo isotope using the direct nuclear reaction 98Mo(n,γ)99Mo by neutrons of the WWR-K reactor using molybdenum (VI) oxide of natural and enriched composition, according to the isotope 98Mo (98.66%) as a target. The possibility of using enriched 98Mo oxide to produce 99Mo was considered. The estimation of the maximum specific activity of 99Mo was obtained in a comparative manner under the same irradiation conditions at the reactor.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
In recent years, there has been an intensive pace of development in the nuclear medicine and radiopharmaceuticals industry. The development of numerous methods of instrumental diagnostics not only does not reduce the demand for radionuclide diagnostics, but indeed contributes to its growth. This is because new methods are being introduced into clinical practice, and new research protocols are being developed using new radiopharmaceuticals. New generations of equipment appear every year.
One of the main methods of diagnosing oncological diseases at an early stage is diagnosis using radioactive isotopes. This approach is used to determine localization; conduct differential diagnostics between malignant and benign formations; assess the activity of tumour cells as a response to the therapeutic effects of drugs or radiopharmaceuticals, or after radiation therapy; and to assess the functional state of organs and physiological systems, and the number of diagnostic procedures. 99mTc is the main isotope used in the most common radionuclide diagnostic methods (more than 80%), which are single-photon emission computed tomography (SPECT) and planar scintigraphy [1]. The main source of the 99mTc isotope is the parent isotope, 99Mo. 99Mo decomposes into technetium-99 m within 66 h, as a result of which half of the activity is lost, and the activity of technetium-99 m decreases within 6 h, so the production of 99Mo/99mTc generators is carried out continuously, one after the other, every two weeks [2].
Due to the fact that the 99mTc radionuclide has optimal nuclear physical properties—low energy of gamma radiation Ey = 140 keV, high yield of 89.1% and a short half-life of 6.01 h comparable to the duration of the study 99mTc isotope is the most promising and widespread gamma-emitting radionuclide for radionuclide diagnostics of oncological diseases worldwide [3]. Figure 1 shows a scheme for the production and decay of 99Mo in 99mTc. Reactor methods are used to obtain the 99mTc isotope of high specific activity, and cyclotron methods are also being developed, but the main ways of producing the 99Mo isotope are fission—that is, fission of uranium by the reaction of 235U(n,f)99Mo with an operating time of 99Mo, practically, without a carrier, and ‘activation’ through the reaction of 98Mo(n,γ)99Mo (Fig. 2). Both methods relate to the reactor method of producing the 99Mo isotope [4,5,6]. For a flux density up to 1014 n cm−2 s−1, it is considered possible to obtain three levels of 99Mo specific activity: by reaction (n,γ), in the case of a natural target of about 1 Ci 99Mo/g Mo, enriched by the 98Mo isotope of the target 4–10 Ci 99Mo/g Mo, and in the case of reaction (n,f), 10,000–30,000 Ci 99Mo/g Mo. However, not every organization can allow the production of 99Mo using the fission method [7, 8].
The main producers of 99Mo implementing these chains are high-tech companies in Australia, Canada, Belgium, Holland, France and South Africa. This makes up 95% of the global market; only 5% is regional production. The release of such drugs is carried out under the status of ‘for clinical trials’, but this is already a fully fledged production, with an entire infrastructure that ensures compliance with the requirements of good manufacturing practice (GMP), which are key in the production of medicines.
The main form of delivery of 99Mo to the consumer is via a 99Mo/ 99mTc generator; the requirements for its quality are determined by its application. After elution of the 99Mo/99mTc-generator, an independent radiopharmaceutical is obtained in the form of sodium pertechnetate, which in turn is the basis for numerous radiopharmaceuticals used in SPECT diagnostics. More than 20 ‘cold’ kits for labelling technetium-99 m are known and additional clinical trials with newly developed kits are currently underway (PSMA, etc.).
However, despite the prospects for using radiopharmaceuticals based on 99mTc, the constant growth in the volume of demand for 99Mo in the Republic of Kazakhstan requires changes to the current production scheme.
This article presents the results of the development of a technological process for the production of the 99Mo isotope at the WWR-K reactor from an enriched and natural target of molybdenum (VI) oxide.
It should also be noted that the Institute of Nuclear Physics (INP), using the research nuclear reactor WWR-K, has been producing molybdenum-99 by activation method from molybdenum (VI) oxide of natural composition for more than 20 years, and produces technetium-99 generators based on it, providing them to centers of nuclear medicine in Kazakhstan. About 120 generators are produced annually. Currently, the INP plans to conclude an agreement for 64 additional generators under the IAEA program to provide the Republic of Kyrgyzstan. Currently, several more nuclear medicine centers are being put into operation in our Republic and one is at the planning stage, which will have an impact on the growing demand for generators.
Theory
The cross-section of the 98Mo(n,γ)99Mo reaction on thermal neutrons is small and amounts to 0.13 barn, although at the same time, for epithermal neutrons (with an energy above 0.4 eV), the cross-section increases to 11.6 barn. So, the optimal choice of the irradiation site in the reactor core can significantly increase the activation of 98Mo. The practically effective cross-section is about 0.5 barn; in some reactors it is possible to realize up to 0.8 barn of effective cross-section. As a result, when irradiated with molybdenum in a stream with a density of 1015 n cm−2 s−1 for 5 days, the specific activity can reach 14.5 Ci/g for a natural target, and for an enriched one about 60 Ci/g. The characteristic values of γ for the irradiation channels of research thermal reactors (except for high-current ones) are γ = 0 ÷ 0.1. Thus, at a flux density of 1014 n cm−2 s−1, a specific activity of about 1 Ci/g is achieved in a target made of natural molybdenum trioxide, and in an enriched one up to 10 Ci/g. Some studies show the possibility of obtaining 99Mo from a natural target with a specific activity of more than 2.5 Ci/g, with an average effective reaction cross-section of about 0.7 bar.
The assembly of the target involves loading a sealed quartz ampoule into an aluminum capsule and combining a plug and an aluminum capsule. After assembly, it is placed in the reactor channel to complete the training program.
Materials and methods
The 99Mo isotope was obtained from molybdenum (VI) oxide of natural (24%) and enriched (98.9%) composition. All chemical reagents and solvents used corresponded to the chemically pure class and were supplied by well-known manufacturers. The purity of the radionuclide 99Mo was determined using gamma spectrometry with a high-purity germanium detector (Ortec). The 152Eu source (OSGI) was used to calibrate the detector for energy and efficiency. A NaI (Tl) ionization chamber was used for measuring total radioactivity (CAPINTEC, INC., CRC.-2PR, USA).
The WWR-K is a light, water-tank-type thermal reactor with a nominal power rating of 6 MW. Demineralized water serves as the moderator and coolant. Demineralized water and beryllium serve as the side reflectors. Core cooling was performed at a regular coolant flow rate of ~ 600 m3/h. The enrichment of uranium-235 in the reactor fuel was 19.7%. The reactor was commissioned in 1967 and in 2016 was converted so it could use low-enriched fuel. Currently, the WWR-K reactor has been operating at 6 MW thermal power with the LEU core.
The reactor is intended for a variety of studies in the fields of fission and fusion materials science, radioisotope production, topaz coloration, doping of silicon, and neutron imaging.
Experimental
The technological process was based on the activation method for producing 99Mo by irradiating starting material containing 98Mo with neutrons from a nuclear reactor.
Natural molybdenum (VI) oxide (24%) enriched in the 98Mo isotope (98.6%) was used as a starting material.
At the first stage of production, the starting material was packed into quartz ampoules.
A quartz ampoule for packaging molybdenum (VI) oxide and subsequent irradiation was manufactured in the laboratory according to developed drawings. The quartz ampoule was sealed by boiling it in distilled water for 10 min.
Test production of the 99Mo isotope was carried out in a series of parallel experiments. The main differences in the experiments were associated with the irradiation of various targets by isotopic composition with a flux of thermal neutrons at the WWR-K reactor, in order to study the issue of obtaining the maximum value of specific activity and optimizing the process of transition to an enriched target Fig. 3.
Results and discussion
The irradiation device was designed for irradiation in the WWR-K reactor and could be installed at any irradiation position. The calculations considered an irradiation position located at the periphery of the reactor core.
Calculated by MCNP6 code the energy distribution of neutrons in the corresponding irradiation position shown in Fig. 4. was used for 98Mo(n,γ)99Mo reaction rate calculations [9,10,11].
Neutron-physical calculations for the irradiation device were carried out with the Monte Carlo method using the MCNP6.2 [12] transport code and the ENDF/B-VII.1 incident-neutron data [13]. The MCNP6 transport code is based on the random simulation of events of the interaction of neutrons and other particles with matter in a material environment. The code makes it possible to calculate various functions representing the convolution of a neutron or photon flux with nuclear physics data [14]. All tallies are normalized to be per starting particle which are normalized to be per fission neutron generation. The F4 tally (track length estimate of cell flux) was utilized for the flux analysis. Neutron energy levels can also be specified with the E4 tally energy card. The flux results are normalized to 6 MW and factor 5.12*1017 is used. Each input file included 500 cycles made of 20 inactive and 480 active cycles with 2,400,000 histories per cycle. As close the Monte Carlo model describes the real situation the calculations accuracy will be better. The most accurate results were obtained using a detailed heterogeneous model. This approach was used to describe the core of the WWR-K reactor. The simulation considered the actual composition of the reactor core, the fuel burnup in the fuel assembly, and the poisoning of the beryllium neutron reflector. The statistical error of the calculations did not exceed 5% Fig. 5.
The irradiation of the target with molybdenum-99 was carried out in the WWR-K reactor for 60 min. Channels of the core periphery were used to irradiate the 98Mo isotope; under these conditions, the thermal neutron flux density of targets with 98Mo was ensured at a level of 9.0∙1013 n cm−2 s−1.
Determination of the number of nuclei (activities) of the 99Mo isotope accumulated during irradiation was carried out using gamma lines (181.1 keV, 366.4 keV, 739.5 keV and 777.9 keV) of irradiated samples of natural isotopic composition and enriched in the 98Mo isotope (Fig. 6). Gamma spectra were measured using a semiconductor detector made of highly pure germanium, starting immediately after the end of irradiation (short-lived isotopes), and long-term measurements were carried out over a month (long-lived isotopes).
Recalculation of the experimental values of the number of produced nuclei of active 99Mo isotopes in activity showed that the maximum that can be obtained is about 1 GBq/g with irradiation for 1 h; in the case of a target of natural composition that is enriched during irradiation with neutrons in the peripheral WWR-K channel, as the irradiation time increases, the difference will increase. Table 1 shows the experimental data, theoretical data of Mo-99 activity obtained by (1) which consider only thermal flux density and production cross-Sect. 0.13 barns, and MCNP calculations data. According to the data, the calculated MCNP data are in very good agreement with practical for enriched and natural targets, respectively (Table 1, Fig. 7).
The yield of 99Mo and the specific activity of 99Mo at the end of irradiation (EOB) are given. The 99Mo yield values are given per 1 g of molybdenum and per neutron flux density of 9.0∙1013 n cm−2 s−1.
As a result of the irradiation of natural molybdenum, the isotopes 93Mo and 101Mo are simultaneously produced. In addition, isotopes such as 187 W (≤ 0.01%), 60 Co ((2 ÷ 6)·10–6%) and 134 Cs ((0,6 ÷ 2)·10–5%) can be formed. This problem is partially solved by prolonged cooling of samples after irradiation in the case of short-lived isotopes or using highly enriched molybdenum with a minimum amount of impurities. Long-lived isotopes, as studies have shown, are contained at a low level and, during the production of the generator, are in the structure of a molybdenum-zirconium gel, when passing through which the saline solution, these impurities are not washed out, in addition, each generator is equipped with a filter made of active aluminum oxide, which is also a barrier to impurities of many metals.Thus, with a 5 day irradiation of 10 g of a natural target (500–600 GBq from saturation yield), one can expect more than 99% radiochemical purity of 99mTc.
Conclusions
Molybdenum-99, from which the technetium-99 m isotope is formed as a result of radioactive decay, is the most popular and promising radioisotope for radionuclide diagnostics.
Molybdenum-99, from which the technetium-99 m isotope is formed as a result of radioactive decay, is the most popular and promising radioisotope for radionuclide diagnostics.
In the Republic of Kazakhstan, only at the WWR-K research reactor is it possible to produce molybdenum-99 using the nuclear activation reaction (n, γ). The reactor has a large number of irradiation positions with different neutron fluxes in it. Based on experimental data, the potential for producing high specific activity from natural and enriched molybdenum (VI) oxide was determined, which is important for the further development of molybdenum production and the possibility of switching to the fragmentation method for its production.
This study has shown the specific activity of 99Mo in the amount of 1 GBq/g when irradiated for an hour, obtained by irradiation at the WWR-K reactor with a thermal neutron flux of 9.0∙1013 n cm−2 s−1, while the central channel flux can reach 1.2∙1014 n cm−2 s−1, allows for a higher specific activity. This specific activity of 99Mo is sufficient to cover the domestic market and neighbouring countries. The activity of the parasitic radioisotopes during this irradiation time is less than 1% of 99Mo activity. Thus, the opportunity for the production of 99Mo at the WWR-K reactor to use in targeted radionuclide diagnostics has been demonstrated.
We have recommendations for increasing the specific activity of 99Mo:
-
− To consider the specific activity of 99Mo by reaction (n,γ), it is necessary to use a target of enriched composition.
-
− To consider the possibility of developing a neutron trap with an increase in the neutron flux and the proportion of epithermal neutrons in the integral neutron flux.
-
- Consider introducing a fragmentation method for producing the 99Mo isotope, but also note that this requires radiochemical separation of nuclides.
References
Rathmann SM, Ahmad Z, Slikboer S, Bilton HA, Snider DP, Valliant JF (2019) The radiopharmaceutical chemistry of technetium-99m. Radiopharm Chem. https://doi.org/10.1007/978-3-319-98947-1_18
Shlygina OE, Borisenko AR (2008) Nuclear medicine. Study guide. Part I. Translated from German - Almaty: Sansam, part 2, p 287
Pupillo G, Esposito J, Haddad F, Michel N, Gambaccini M (2015) Accelerator-based production of Mo-99: a comparison between the Mo-100(p, x) and Zr-96(alpha, n) reactions. J Radioanal Nucl Chem 305(1):73–78. https://doi.org/10.1007/s10967-015-4091-8
Gurin AN, Chakrova YT, Medvedeva ZV, Soloninkina SG (2022) Prospects for the development of nuclear medicine in the republic of Kazakhstan: reactor isotopes of rare earth elements for therapy. NNC RK Bull 2:46–52. https://doi.org/10.52676/1729-7885-2022-2-46-52
Pupillo G, Esposito J, Gambaccini M, Haddad F, Michel N (2014) Experimental cross section evaluation for innovative Mo-99 production via the (alpha, n) reaction on Zr-96 target. J Radioanal Nucl Chem 302(2):911–917. https://doi.org/10.1007/s10967-014-3321-9
Welsh J, Bigles CI, Valderrabano A, Future US (2015) Supply of Mo-99 production through fission based LEU/LEU technology. J Radioanal Nucl Chem 305(1):9–12. https://doi.org/10.1007/s10967-015-4090-9
Nawar MF, Türler A (2022) New strategies for a sustainable 99mTc supply to meet increasing medical demands: promising solutions for current problems. Front Chem 10:926258. https://doi.org/10.3389/fchem.2022.926258
Kodina GE (2019) Methods of obtaining radiopharmaceuticals and radionuclide generators for nuclear medicine: textbook for universities / Kodina G. E. - Moscow: Publishing House of MEI, 2019. - ISBN 978–5–383–01241–3. - Text : electronic // EBS "Student Consultant": [website]. - URL : https://www.studentlibrary.ru/book/ISBN9785383012413.html
Shaimerdenov AA, Arinkin FM, Gizatulin ShKh, Dyussambayev DS, Koltochnik SN, Chakrov PV, Chekushina LV (2017) Conversion of WWR-K research reactor to LEU fuel. At Energ 123:15–20. https://doi.org/10.1007/s10512-017-0294-0
Shaimerdenov AA, Nakipov DA, Arinkin FM et al (2018) The 50th anniversary of the WWR-K research reactor. Phys Atom Nuclei 81:1408. https://doi.org/10.1134/S1063778818100162
Shaimerdenov A, Gizatulin S, Dyussambayev D, Askerbekov S, Kenzhina I (2020) The WWR-K reactor experimental base for studies of the tritium release from materials under irradiation. Fusion Sci Technol 76:304–313. https://doi.org/10.1080/15361055.2020.1711852
Werner CJ, Bull JS, Solomon CJ et al. (2018) MCNP6.2 Release Notes", LA-UR-18–20808
Brown DA, Chadwick MB, Capote R, Kahler AC, Trkov A, Herman MW, end, et al (2011) ENDF/B-VII.1 nuclear data for science and technology: cross sections, covariances, fission product yields and decay data. Nucl Data Sheets 112:2887–2996
Sairanbayev D, Koltochnik S, Shaimerdenov A, Chakrova Y, Gurin A, Kenzhin Y (2020) Analysis of lutetium-177 production at the WWR-K research reactor. Appl Radiat Isotopes. https://doi.org/10.1016/j.apradiso.2020.109561
Acknowledgements
This research is funded by the Ministry of Science and Higher Education of the Republic of Kazakhstan (Grant No. AP14972851).
Funding
The research leading to these results received funding from the Ministry of Science and Higher Education of the Republic of Kazakhstan under Grant Agreement No AP14972851.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare that are relevant to the content of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gurin, A., Chakrova, Y., Matveyeva, I. et al. Analysis of molybdenum-99 production at the WWR-K research reactor. J Radioanal Nucl Chem 333, 1719–1724 (2024). https://doi.org/10.1007/s10967-024-09410-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-024-09410-z